Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.34T | 2.81T | 1.63T | 1.58T | 1.42T | 1.33T | Gross Profit |
701.79B | 1.17T | -14.62B | -348.00M | -43.45B | -73.36B | EBIT |
462.93B | -172.84B | 360.57B | 499.40B | 283.13B | 408.54B | EBITDA |
473.97B | 0.00 | 714.01B | 829.75B | 599.09B | 712.74B | Net Income Common Stockholders |
369.90B | 346.13B | 290.34B | 317.38B | 192.38B | 302.70B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.85T | 1.05T | 3.47T | 3.13T | 2.96T | 2.61T | Total Assets |
7.74T | 16.32T | 15.27T | 14.27T | 13.56T | 13.07T | Total Debt |
4.41T | 6.20T | 5.72T | 4.87T | 4.72T | 4.62T | Net Debt |
3.77T | 5.17T | 4.49T | 3.91T | 3.77T | 3.63T | Total Liabilities |
6.40T | 12.30T | 11.84T | 10.90T | 10.46T | 10.00T | Stockholders Equity |
1.30T | 3.94T | 3.36T | 3.26T | 3.03T | 2.99T |
Cash Flow | Free Cash Flow | ||||
681.09B | 42.53B | -166.99B | 186.07B | 341.72B | 49.55B | Operating Cash Flow |
1.06T | 1.24T | 913.09B | 1.10T | 1.10T | 1.04T | Investing Cash Flow |
-949.32B | -1.37T | -1.10T | -808.85B | -1.21T | -1.47T | Financing Cash Flow |
14.18B | -85.48B | 438.31B | -306.62B | 39.88B | 288.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $37.00B | 8.30 | 24.68% | 1.90% | 15.46% | 45.83% | |
71 Outperform | $21.35B | 8.21 | 10.07% | 3.47% | 0.31% | 34.40% | |
69 Neutral | $9.87B | 17.85 | 6.63% | 3.74% | 3.41% | -12.41% | |
69 Neutral | $3.39B | 3.70 | 129.04% | 9.28% | -3.38% | 63.33% | |
66 Neutral | $4.90B | 9.68 | 15.96% | 10.14% | 7.96% | -20.11% | |
65 Neutral | $17.03B | 5.12 | 22.96% | 2.28% | 19.73% | 65.57% | |
63 Neutral | $12.86B | 9.19 | 9.16% | 4.78% | 16.31% | -8.97% |